A biotechnology firm, headed by Owen Sound native John Lewis, has received the go-ahead to begin Phase 2 clinical trials of its made-in-Canada, single-dose COVID-19 DNA vaccine candidate. Read More
A biotechnology firm, headed by Owen Sound native John Lewis, has received the go-ahead to begin Phase 2 clinical trials of its made-in-Canada, single-dose COVID-19 DNA vaccine candidate. Read More